Participants 111 136 4
granulocytopenic patients
Participants 349 438 4
prospective double-blind study of empiric antibiotic therapy in granulocytopenic patients
Participants 440 682 9
Patients were stratified into two groups: favorable-prognosis, group 1 (carcinoma, lymphoma, multiple myeloma), or unfavorable-prognosis, group 2 (acute leukemia, bone marrow transplantation), based on anticipated duration of granulocytopenia
